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Objective(s): N-acetylcysteine (NAC) has gained attention recently in dermatology as a unique anti-
oxidant. In light of progress in nanotechnological methods, it was hypothesized that loading NAC onto 
nanofibers would positively affect skin wound healing. The objective of this study was to fabricate 
NAC-loaded electrospun mats and test their effect on wound healing in vivo and in vitro.     
Materials and Methods: Polyvinyl alcohol (PVA)-based mats loaded with NAC at three concentrations were 
electrospun and characterized in terms of physicochemical properties and drug release profile. Human 
fibroblast cells (in vitro) and mouse full-thickness skin wounds (in vivo) were treated with mats for 5 and 
14 days, respectively. Wound area, tissue histopathology, fibroblast proliferation and cellular oxidative state 
were evaluated.
Results: Mats containing 5% PVA/NAC showed thinner fibers with suitable physicochemical 
properties and a sustained drug release profile. PVA/NAC (5%) mats enhanced fibroblast proliferation 
and attachment in vitro. The mats resulted in significant wound closure with high levels of re-
epithelialization and collagen fiber synthesis on day 14 post-surgery in vivo. The mats also reduced 
granulation tissue and edematous stroma to a higher extent. These findings were accompanied by a 
significant decrease in tissue lipid peroxidation and higher superoxide dismutase activity, which may 
explain how NAC improved wound healing.
Conclusion: We propose an NAC-loaded nanofibrous mat that takes the advantage of a porous 
nanoscaffold structure to release NAC in a sustained manner. This mat may be a promising candidate 
for further clinical evaluation.
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Introduction
Skin injuries, burns, diabetic ulcers and other 
insults to the intact skin are considerable challenges in 
dermatology and skin care. The selection of appropriate 
wound-healing agents or dressings plays a pivotal role in 
skin tissue restoration, prevention of dermal or systemic 
infections, and ultimately in the aesthetic outcome of 
wound healing. An alternative therapeutic approach to 
conventional topical wound-healing formulations such 
as gels, creams, ointments etc. is the use of drug-loaded 
engineered scaffolds as skin wound dressings (1).
 Drug-loaded wound dressings with a nanofibrous 
structure possess a number of key characteristics 
required for good wound healing, such as resemblance 
to the extracellular matrix, attachment to dermal 
fibroblasts  and high healing efficiency, anti-microbial 
properties and high surface-to-volume ratio, wettability, 
and porosity. Electrospinning polymer solutions 
are widely utilized to fabricate nanofibers. In this 
connection, a variety of polymers of natural (e.g. gelatin, 
chitosan, and alginate) or synthetic origin (e.g. polyvinyl 
alcohol and polyethylene oxide) have been used for this 
purpose (2). 
The process of wound healing is complex and involves 
several successive but overlapping phases, including 
hemostasis, inflammation, proliferation and maturation 
(remodeling). Indeed, coordinated actions among all 
agents in the wound healing process are required for 
complete skin regeneration with minimal side effects 
such as infections or scar formation (3). The reduction/
oxidation (redox) status of the wounded tissue is a major 
determinant among the many cellular and subcellular 
factors that influence the wound healing process. 
Reactive oxygen species (ROS) can be considered as 
second messengers acting directly or indirectly on the 
cells involved in wound healing (4). Although oxidative 
stress may be partly beneficial in wound healing, excess 
oxidative stress can disturb the normal wound repair 
process by inhibiting major biological activities required 
for appropriate skin regeneration (5). At the molecular 
level, gene expression of matrix metaloproteinases 
(MMP) and proinflammatory cytokines may be increased 
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by ROS. In contrast, excess ROS production can directly 
destroy extracellular matrix proteins or indirectly 
affect them by inducing proteolysis. Moreover, ROS may 
impair the actions of skin fibroblasts and keratinocytes 
(6). Accordingly, searching for agents with anti-oxidant 
properties may lead to the discovery of promising 
wound-healing candidates for skin wound care. 
N-acetylcysteine (NAC) is a thiol-containing 
compound with significant anti-oxidant activity that has 
a number of clinical applications (7). This compound 
can either directly scavenge free radicals or indirectly 
counteract them by taking part in the production of 
glutathione, a major cellular anti-oxidant molecule (8). 
Accordingly, oral and parenteral NAC was suggested 
as a promising agent for wound healing in some 
experimental and clinical studies (9, 10). In light of the 
known anti-oxidant activity of NAC on one hand, and 
the advantages of applying nanotechnology in designing 
nanofibrous mats as wound dressings on the other 
hand, the objective of the present study was to fabricate, 
characterize and evaluate the wound healing efficacy of 
NAC-loaded electrospun nanofibers in vitro and in vivo. 
Materials and Methods
Materials
NAC, polyvinyl alcohol (PVA) (MW 72,000 Da) and 
phosphate-buffered saline (PBS)  tablets were supplied 
by Merck Co. (Germany). Glutaraldehyde 25% (v/v) was 
purchased from Fluka Co. (UK). Ketamine and xylazine 
vials were supplied by Alfasan Co. (the Netherlands). 
Dulbecco’s modified Eagle’s medium (DMEM) and fetal 
bovine serum (FBS) were purchased from Gibco Co. 
(Germany). Penicillin/streptomycin and DMSO were 
purchased from Sigma Co. (USA), and the cell viability 
reagent MTT (3-(4, 5-dimethyl-2-thiazolyl)-2,5-
diphenyl-2H-tetrazolium bromide) was from BioFroxx 
Co. (Germany).  Double distilled water (dd H2O) was 
used as the solvent to fabricate mats.
Preparation of polymer solutions and electrospun mats
The PVA concentration and electrospinning 
parameters were adopted from previous work with 
some modifications (11). In brief, PVA solution at a 
concentration of 6% (w/v) was prepared by dissolving 
PVA powder in hot water (80 °C) with stirring for 3 hrs. 
After the PVA solution had cooled, NAC powder was 
added to the solution to obtain a final concentrations 
of 2.5 or 5% (w/v). NAC-loaded PVA solutions were 
stirred for 6 hrs until complete dissolution. To fabricate 
nanofibrous mats, a mono-jet electrospinning apparatus 
manufactured by Fanavaran Nano Meghyas Co. (Iran) 
was used. A 5-ml syringe attached to a blunt-head 
needle (18 G) was used to inject polymer solutions. The 
distance from the needle tip to the collector was set at 
12 cm with an applied voltage of 15-17 kV. Injection rate 
was adjusted to 0.25 ml/hr, and the electrospun fibers 
were collected onto aluminum foil on a rotating drum 
(120 rpm). The electrospun fibers were subsequently 
dried under a vacuum for 6 hrs and carefully peeled 
off the foil. Electrospun fibers fabricated from PVA 6% 
(w/v) solution containing 0%, 2.5% and 5% NAC (w/v) 
were designated hereafter neat PVA, PVA/NAC 2.5% and 
PVA/NAC 5% mats, respectively. To cross-link mats, they 
were exposed to 10% (v/v) glutaraldehyde solution 
vapor in an enclosed desiccator dish for 12 hrs at room 
temperature. The mats were subsequently washed with 
dd H2O to remove excess unreacted glutaraldehyde. 
Characterization of the electrospun mats
Size and morphology of the electrospun mats were 
evaluated with scanning electron microscopy (SEM) 
(CamScan-MV2300, US). A thin layer of the electrospun 
mat (1 × 1 cm) was coated with gold, and an acceleration 
voltage of 20 kV was used to obtain SEM micrographs. 
The images were then imported into ImageJ Software v. 
1.47 (National Institutes of Health, USA) to determine 
fiber diameters. Mean fiber diameter in each mat 
sample was calculated by measuring the diameter of at 
least 100 random fibers in that sample.
Swelling and weight loss tests
To investigate swelling, mats were immersed in 
PBS buffer (pH 7.4) at room temperature for 1 hr. The 
degree of swelling was determined based the following 
equation:
where M is the weight of each sample after immersion 
in the PBS buffer solution and Mi is the initial weight of 
that sample in the dry state. In addition, weight loss 
of the mats as a measure of their structural resistance 
against aqueous media was determined. Small pieces 
of mats (~50 mg) were accurately weighed initially and 
then immersed in 20 ml of PBS (pH 7.4) at 37 °C for 24, 
48, 72 or 96 hrs. At each time point, the mat remnants 
were removed from the buffer solution, washed gently 
with dd H2O, and desiccated under vacuum to a final 
constant weight. Equation 2 was used to calculate the 
extent of weight loss (%) for each mat sample at the 
specified times:
where Mi is the initial weight of each sample (dry 
weight before immersion in PBS) and Mt is the sample 
weight at time t (dry weight after immersion in PBS).
Porosity test
Porosity of the mats was calculated by the following 
equation:
where ρm is the apparent calculated density and ρ0 is 
the density of the polymer in its bulk form [ρ0 (PVA) = 1.3 g/
cm3]. In order to calculate apparent density (ρm), the mats 
were cut into 2 × 2 cm squares, stacked together to yield an 
average thickness of about 200 µm according to a digital 
caliper, and then weighed in a digital precision scale. 
Finally, the mass-to-volume ratio of each mat sample (ρm) 
was calculated for use in the porosity equation.
Fourier-transform infrared spectroscopy (FTIR)
The chemical structure of the electrospun PVA-based 
mat with and without NAC was characterized with 
FTIR spectroscopy (Perkin Elmer, Frontier, USA). The 
electrospun mats were powdered and mixed with KBr at 
1:100 (w/w). A scanning range of 400–4000 cm-1 with 4 
cm resolution was used to record the spectra.
Drug release profile and kinetic modeling
To determine NAC release behavior from the 
electrospun mats, NAC-loaded mats (25 mg) were 
immersed in 25 ml PBS buffer (pH = 7.4,  37 °C) under 
constant gentle shaking. After 1, 2, 3, 6, 12, 24, 72 
and 96 hr,  2 ml of the solution was sampled for NAC 
spectrophotometric measurement at 193 nm according 
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to a calibration curve in a range of 0 to 70 µg/ml NAC. 
The missing volume was replaced with fresh PBS buffer 
solution (2 ml) so that total volume remained constant. 
Cumulative drug release (%) was calculated based on 
the following equation:
where Ct is the NAC concentration at the specified time, 
and C∞ denotes the NAC maximum final concentration at 
plateau.
To further investigate the release mechanism, the 
release data were fitted into a number of known release 
kinetic models, i.e. zero order, first order, Higuchi and 
Korsmeyer–Peppas models (equations 5 to 8) (12). 
The last model is well-established for describing drug 
release kinetics from polymer matrices (13).
where k0, k1, kH and kP are the release rate constants, 
n is the diffusion exponent for the release mechanism 
in the Korsmeyer–Peppas model. Ct and C∞ were defined 
previously.  
In vitro cell proliferation assay
The MTT assay was used to assess the in vitro effects 
of NAC-loaded nanofibers on cell proliferation and 
biocompatibility in cultured human foreskin fibroblasts 
(HNFF-P18). Briefly, HNFF-P18 cells (Pasteur Institute 
Cell Bank, Iran) were cultured in DMEM supplemented 
with 10% (v/v) FBS, penicillin (100 U/ml) and 
streptomycin (100 μg/ml) in a 5% CO2 incubator at 37 
°C. Cells from the third and fourth passages were seeded 
onto DMEM-soaked nanofibers in a 24-well multi-plate 
at a density of 2.5 × 104 cells per well and incubated for 1, 
3 and 5 days. Sterile MTT solution (5 mg/ml) was added 
to each well, and then the cell-seeded nanofibers were 
incubated at 37 °C for 4 hrs. Subsequently, absorbance 
was read with a microplate reader (Power waveX, Bio-
tek Instruments, USA) at 570 nm. The proliferation rate 
(%) of fibroblasts was calculated with the following 
formula in which As, Ac and Ab denote absorbance of the 
sample, control and blank, respectively. Each experiment 
was repeated four times.
 
In vivo skin wound healing  
Animals and wound model
The inbred male albino mice (25–30 g) used for 
the wound healing experiment were purchased from 
the experimental animal breeding center of Bushehr 
University of Medical Sciences (BPUMS), Iran. They 
were transported to the experimental lab 1 week before 
the onset of experiments, to allow for familiarization. 
All mice had free access to water and food pellets. The 
temperature was kept at 24 °C, with a 12-hr light-dark 
cycle. All animals were handled in accordance with 
guidelines for animal care and with the approval of the 
Ethics Committee of BPUMS. 
The mice were initially anesthetized by intraperitoneal 
injection of a mixture of ketamine/xylazine (60/10 
mg/kg). The interscapular region was chosen for 
wound creation because this region was inaccessible 
to the animals with their paws or mouth. The area was 
shaved and disinfected with ethanol 70%, and a circular 
excisional full-thickness wound of 1 cm in diameter was 
made with sharp, curved-tip surgical scissors. Care was 
taken to excise the skin smoothly and not to damage the 
layers beneath the skin.
Experimental design
A total of 40 mice were randomly and equally 
distributed in four experimental groups. Topical 
treatments were as follow: Normal saline (group 1), 
NAC 5% (w/v) in PVA gel (group 2), neat PVA mat 
[without NAC] (group 3), or PVA/NAC 5% mat (group 
4). An NAC gel formulation condition (treatment group 
2) was intentionally included so that comparisons could 
be made between nanofibers and the gel formulation of 
NAC. The gel was made up of PVA 6% (w/v) solution, 
which contained NAC at a final concentration of 5% 
(w/v). Because PVA solution behaves rheologically 
more like gels than aqueous fluids, we used the term 
PVA gel.  To reduce microbial contamination, all topical 
preparations were sterilized under ultraviolet-C light 
for 30 min before application on the wounds. After the 
appropriate treatment was applied, the wounds were 
bandaged with simple sterile gauze. All animals were 
treated at 24-hr intervals. Half of the animals in each 
group received treatment for 7 days, while the other 
half received treatment until day 14. To determine 
changes in wound area, the wounds were photographed 
with a digital camera immediately after wound creation 
(day 0) and on days 3, 7, and 14 post-surgery. During 
photography, a ruler was placed near  the wound for 
scaling purpose. On days 7 or 14, the wound tissue plus a 
small portion of the surrounding intact skin was excised. 
Half of the sample was stored in 10% formalin for 
histopathological analysis, and the other half was stored 
at  80 °C for biochemical assay. After the wound biopsies 
were obtained, the animals were killed by intracardial 
injection of a high dose of ketamine/xylazine. 
Macroscopic (wound area) measurements
Photographs of wounds were processed with ImageJ 
Software v. 1.47 to calculate the wound areas. For 
each skin wound, the area calculated on different days 
post-surgery was normalized to its area on day 0. This 
compensated for any variations in the size of the initial 
wound. Hence, macroscopic data were reported as area 
(%) on days 3, 7 or 14 post-surgery as calculated by the 
following equation:
where Ad is wound area on the selected day and A0 is 
wound area on day 0 (the day of surgery). 
Microscopic (histopathologic) measurements
Hematoxylin-eosin (H and E) and Masson’s trichrome 
stains were used to evaluate the histopathological 
changes in wound tissues on day 7 and 14 post-
surgery. The tissue preparation and staining process 
are described briefly as follow: cross-sections were 
obtained of the excised wounds to include both wound 
tissue and the neighboring intact skin. Samples were 
fixed in 3.7% formalin, embedded in paraffin, cut into 
5-µm sections, and stained in accordance with routine 
protocols for H and E and Masson’s trichrome staining. 
The histopathological parameters recorded in this 
study were re-epithelialization, neovascularization, 
collagen density, granulation tissue, and the levels of 
fibroblasts and polymorphonuclear (PMN) leukocytes. 
These parameters were scored as 0 (absent), 1 (mild), 
2 (moderate), or 3 (severe) based on a semiquantitative 
scaling system proposed in a previous study (14) with 
some modifications (Table 1).
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Anti-oxidant activity assay
Skin wound tissues were homogenized in ice-cold 
PBS buffer (pH=7.4) and centrifuged at 3500 rpm at 4 
°C for 20 min. The supernatants were then separated 
for anti-oxidant assay. The Bradford method was used 
to determine total protein levels with bovine serum 
albumin as the standard protein (15). The redox status 
in the wounded tissues was assessed by measuring the 
level of lipid peroxidation and superoxide dismutase 
(SOD) activity. Lipid peroxidation was determined based 
on the thiobarbituric acid reactive substances (TBARS) 
method, in which the levels of malondialdehyde (MDA) 
were measured at 532 nm and reported in nmol/
mg protein. The SOD activity assay was based on the 
conversion of superoxide anions to hydrogen peroxide 
and oxygen molecules by SOD, and activity in sample 
tissues was reported as units/mg protein. These assays 
were performed according to the instructions provided 
by the manufacturers of the MDA and SOD assay 
commercial kits (Abnova, Taiwan).
Statistical analysis
All data from all experiments and assays were 
obtained from at least triplicate measurements and 
were reported as the mean±standard deviation except 
where noted in the text. The Kruskal–Wallis test followed 
by pairwise comparisons was used to analyze the 
microscopic (histopathological) data. The macroscopic 
(wound area) and other data were analyzed with one-
way ANOVA and the Tukey’s post hoc test. All differences 
at P<0.05 were considered statistically significant. All 
data analyses were performed with SPSS® Software 
version 21.
Results
Fiber size and distribution
SEM photomicrographs of electrospun fibers with 
different NAC concentrations are shown in Figure 1 
together with the corresponding size distribution graphs. 
Non-woven, beadless and uniform nanofibers were 
observed at different NAC concentrations. Fiber thickness 
was significantly influenced by the presence of NAC. Mean 
fiber diameter in the PVA/NAC 5% mat was 26.3% lower 
than in PVA/NAC 2.5% mats and 29.6%  lower than in 
neat PVA mats (F=5.23, df=2, P=0.024) (Table 2).
Scale Re-epithelialization PMNs (#) Fibroblasts (#) Collagen density New vessels (#) Granulation tissue 
0 Absent Absent Absent Absent Absent Absent 
1 Covering <50% of the wound <5 1-10 Mild <5 Mild  edematous stroma 
2 Covering >50% of the wound 5-15 10-20 Moderate 5-15 Moderate edematous stroma 
3 Covering 100% of the wound with keratinization >15 >20 Abundant >15 Abundant edematous stroma 
 
  
Table 1. Explanation of the scale used to evaluate pathology parameters in high-power microscopic fields
 
  
Figure 1. Morphology and the corresponding size distribution of nanofibers in neat PVA, PVA/NAC 2.5% and PVA/NAC 5% mats. Scale bars 
represent 5 µm in the large SEM photos. Inset photos at lower magnifications are also provided for each mat type. NAC: N-acetylcysteine; PVA: 
Polyvinyl alcohol
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Swelling and weight loss
Percentage swelling rates in the electrospun mats are 
presented in Table 2. The degree of swelling in NAC 5% 
mats was slightly higher than that in NAC 2.5% and neat 
PVA mats. However, the differences were not statistically 
significant (F=0.83, df=2, P=0.16). Weight loss assays 
were conducted to assess structural resistance of the 
electrospun scaffolds against the surrounding medium. 
Figure 2 shows the trends in weight loss in all three 
mats (with and without NAC) at different time intervals 
upon incubation in PBS buffer. Weight loss in all mats 
increased slightly with time. Although weight loss in 
the PVA/NAC 2.5% and 5% mats appeared to be greater 
than that in the neat PVA mat, but the differences were 
not statistically significant (F=1.09, df=2, P=0.18).
Porosity of the mats
Porosity values were high, a finding that favors 
cellular accommodation and attachment (Table 2). 
Porosity in the PVA/NAC 5% mat was 11.0% higher than 
the neat PVA mat and 4.4% higher than the PVA/NAC 
2.5% mat. The higher porosity of the PVA/NAC 5% mat 
may be related to its thinner fiber diameter.
FTIR analysis
The FTIR spectra of pure PVA and NAC powders as 
well as PVA/NAC electrospun mats are shown in Figure 
3. For the PVA/NAC mat, the spectra of both cross-
linked and non-cross-linked fibers are shown.  For 
the PVA spectrum (Figure 3a), the absorption peaks 
at 1268, 1085 and 835 cm-1 can be attributed to C-H 
bending, C-O stretching and C-C stretching vibrations, 
respectively (16). Stretching vibration of the residual 
acetyl (C-C=O) group in PVA produced a sharp peak 
at 1724 cm-1. The broad peak at 3431 cm-1 was due to 
stretching of the hydroxyl group (-OH) in PVA. The peak 
at 2919 cm-1 corresponded to asymmetric bending of 
C-H group. Figure (3b) shows the characteristic FTIR 
profile of NAC, in which peaks at 3378, 2547 and 1720 
cm-1 corresponded to the stretching vibrations of N-H, 
S-H and C=O groups in the NAC molecule, respectively 
(17). Adjacent peaks at 1550 and 1600 cm-1 represented 
the carboxyl group (COO-) in NAC (18). FTIR spectra for 
PVA/NAC mats before cross-linking with glutaraldehyde 
(Figure 3c) revealed two distinctive peaks at 3377, 
and 2543 cm-1, which corresponded well with the 
aforementioned peaks at 3378 (N-H) and 2547 (S-
H) cm-1 for NAC. Other peaks (e.g. 1550 and 1600 
cm-1) for NAC were also present in the PVA/NAC mat 
spectrum. The cross-linked PVA/NAC fibers (Figure 3d) 
demonstrated a similar spectrum although intensity of 
the –OH peak (3431 cm-1) reduced compared to non-
cross-linked PVA/NAC fibers. This reflected the reaction 
of glutaraldehyde with some of the hydroxyl groups 
in PVA (19). Notably, NAC remained mainly unreacted 
after cross-linking, since the diagnostic NAC peaks at 
3377, 2543 and 1720 cm-1 were still present (Figure 
3d). Hence, the NAC present in the electrospun mats 
Table 2. Size, porosity and swelling of PVA-based nanofibers with different NAC concentrations
* and # indicate significant difference (P<0.05) compared to neat PVA or PVA/NAC 2.5% mats, respectively
 NAC: N-acetylcysteine; PVA: Polyvinyl alcohol
Fiber composition 
Fiber diameter (nm) 
Porosity (%)±sd Swelling (%)±sd 
min max mean±sd 
Neat PVA 186 400 263±62 78.3±7.0 89.3±7.0 
PVA/NAC 2.5% 181 412 251±45 85.3±6.5 94.6±7.5 
PVA/NAC 5% 153 219 185±33*# 89.3±8.5 110.3±8.6 
 
  
 
  
Figure 2. Weight loss (gravimetric assay) in different PVA-based 
electrospun mats in PBS buffer solution (pH 7.4, 37 °C) at different 
time intervals
 PVA: Polyvinyl alcohol
 
  
Figure 3. FTIR spectra of (a) pure PVA powder, (b) pure NAC powder, 
and the PVA/NAC electrospun mat (c) before and (d) after cross-
linking with glutaraldehyde vapor. The main diagnostic peaks are 
marked in each spectrum
NAC: N-acetylcysteine; PVA: Polyvinyl alcohol; FFTIR: Fourier-
transform infrared spectroscopy
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did not undergo major, significant interactions with 
PVA molecules before or after cross-linking. Of note, the 
observed changes in the peak shapes and wavenumbers 
in the PVA/NAC mat spectrum (before cross-linking) 
compared to the spectra for each pure agent can be 
explained by hydrogen bonds between electronegative 
(oxygen and nitrogen) and hydrogen atoms in the 
agents. Figure 4 shows the proposed hydrogen bonding 
between the NAC and PVA molecules.
NAC release assay
Drug release profiles of PVA-based mats loaded with 
NAC 2.5% and 5% for a period of 120 hrs are depicted in 
Figure 5. The release of NAC from all mats was relatively 
fast, with approximately 80% of the drug being released 
within the first 24 hr. This was followed by a sustained 
release rate for the rest of the observation period. Mats 
containing both 2.5% and 5% NAC showed almost 
identical release profiles although the PVA/NAC 5% mat 
exhibited slightly faster release. The final concentration 
of NAC released was 22.2±0.7 µg/ml for PVA/NAC 2.5% 
mats and 45.9±2.3 µg/ml for PVA/NAC 5% mats.
Table 3 presents the results of fitting release data to 
different mathematical kinetics models. Except for the 
zero-order model, other models showed convincing fits 
in terms of regression coefficients,  with the highest 
coefficient in the Korsmeyer–Peppas model (R2=0.97). 
Values of n (diffusion exponent) in this model were 0.46 
and 0.54 for PVA/NAC 2.5% and 5% mats, respectively. 
Because these values lie within the range of 0.45 < n < 
1, they imply a non-Fickian release mechanism in which 
release is governed by both drug diffusion and polymer 
swelling (20).
Biocompatibility characterization of nanofiber 
scaffolds by MTT assay and SEM
Figure 6 a shows the percentage cell proliferation rate 
on days 1, 3 and 5 of incubation with the PVA/NAC 5% 
mat. This mat formulation enhanced the proliferation 
of human foreskin fibroblasts to a significantly higher 
extent than in the control group (cells without the 
scaffold) on day 5 of incubation (P < 0.001). Figure 6b 
shows a SEM image of activated fibroblasts on the PVA/
NAC 5% scaffold. Fibroblasts were fully extended and 
formed pseudopods, which facilitated interactions with 
the drug-eluting nanofibers. The SEM image also shows 
appropriate morphology of the fibroblasts and confirms 
the results of MTT assay. 
 
  
Figure 4. Schematic presentation of possible hydrogen-bonding 
interactions between PVA and NAC molecules in the electrospun 
nanofiber mats. NAC: N-acetylcysteine, PVA: Polyvinyl alcohol
 
  
Figure 5. Cumulative drug release (%) profiles of PVA/NAC 2.5% and 
5% mats in PBS buffer solution (pH 7.4, 37 °C). NAC concentration was 
measured at 1, 2, 3, 6, 12, 24, 48, 72, 96 and 120 hrs (n =3)
NAC: N-acetylcysteine; PVA: Polyvinyl alcohol; PBS: phosphate-
buffered saline
 
  
Figure 6. (a) Proliferation rate (%) of human foreskin fibroblasts 
incubated with PVA/NAC 5% mats for 1, 3 and 5 days. Bars represent 
the mean±standard deviation (n=4/group). (b) Representative SEM 
photograph of a fibroblast showing considerable stretching and 
adhesion to the nanofiber scaffold after 5 days of incubation with the 
PVA/NAC 5% mat
NAC: N-acetylcysteine; PVA: Polyvinyl alcohol
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Macroscopic (wound area) analyses
Figure 7 shows representative photos of wounds 
after treatment for different post-surgical periods with 
normal saline, NAC 5% gel, neat PVA or PVA/NAC 5% 
mats. In addition, the corresponding means wound 
areas are reported in Table 4. The largest wound area 
was observed in the normal saline group on day 3 
post-surgery (86.7%±4.7), and the smallest area was 
observed in wounds treated with a PVA/NAC 5% mat on 
day 14 post-surgery (14.1%±3.0). As expected, wounds 
in all experimental groups had smaller areas on day 
14 than on days 3 or 7 post-surgery. One-way ANOVA 
disclosed significant differences in mean of wound areas 
between the experimental groups on day 7 (F=8.89, df= 
3, P=0.0003) and day 14 post-surgery (F=4.50, df = 3, 
P=0.012). Post hoc analysis showed that PVA/NAC 5% 
mats, on day 7, resulted in significantly smaller wound 
sizes than did normal saline (20%, P=0.0003) or neat 
PVA mats (15.8%, P=0.007). On day 14 post-surgery, 
PVA/NAC 5% mats led to further reductions in wound 
size compared to normal saline (35%, P=0.012) or neat 
PVA mats (31.5%, P=0.037). Of note, treatment with 
NAC 5% gel yielded significantly better results than 
normal saline on day 7 (P=0.036) but not on day 14 
post-surgery (P=0.770).
Microscopic (histopathologic) analyses 
Representative photomicrographs of H and E-stained 
wound tissues obtained on days 7 or 14 post-surgery 
are shown in Figure 8, and the corresponding wound 
 
Mat 
R2 
Zero order First order Higuchi Korsmeyer–Peppas (n) 
PVA/NAC 2.5% 0.60 0.96 0.95 0.97 (0.46) 
PVA/NAC 5% 0.63 0.96 0.96 0.97 (0.54) 
 
  
Table 3. Regression coefficients obtained from fitting NAC release data to different kinetics models
n: Diffusion exponent in the Korsmeyer–Peppas model. NAC: N-acetylcysteine, PVA: Polyvinyl alcohol
 
  
Figure 7. Representative photos of full-thickness skin wounds treated 
with (a) normal saline, (b) NAC 5% in PVA gel, (c) neat PVA mats, or 
(d) PVA/NAC 5% mats on days 0, 3, 7 and 14 post-surgery
NAC: N-acetylcysteine; PVA: Polyvinyl alcohol
 
  
Figure 8. Representative low magnification (×40) photomicrographs 
of H and E-stained wound tissues treated with (a) normal saline, 
(b) NAC 5% in PVA gel, (c) neat PVA mat, or (d) PVA/NAC 5% mat 
after 7 or 14 days of treatment. Arrows (→) show wound margins 
and arrowheads ( ) show re-epithelialization fronts. Wound 
stroma beneath the re-epithelialized area lacked skin adnexa in all 
experimental groups on day 14 post-surgery
NAC: N-acetylcysteine; PVA: Polyvinyl alcohol
 
Treatment Wound area (%) 
Day 3 Day 7 Day 14 
Normal saline 86.7±4.7 56.5±4.7 21.7 ± 4.7 
NAC 5% gel 80.1±4.4 49.7±4.2* 19.5 ± 4.2 
Neat PVA mat 82.3±4.5 53.7±4.5 20.6 ± 4.5 
PVA/NAC 5% mat 79.4±6.1 45.2±3.8*, # 14.1± 3.0*, # 
 
 
Table 4. Wound area (mean ± standard deviation) on days 3, 7 and 14 
post-surgery after topical treatment with normal saline, NAC 5% gel, 
neat PVA or PVA/NAC 5% mats (n=5–8 per group)
* and # denote statistical significance (P<0.05) compared to normal 
saline or the neat PVA mat, respectively, on each day
NAC: N-acetylcysteine; PVA: Polyvinyl alcohol
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tissues stained with Masson’s trichrome are presented 
in Figure 9. Seven days after wound creation in normal 
saline group, highly edematous granulation tissue was 
observed with high levels of PMNs and new vessels 
with thin endothelia (neovascularization) and low 
levels of re-epithelialization and fibroblasts (Figure 8a). 
Collagen production was negligible (Figure 9a). Partial 
improvements in wound healing were observed on day 
14, but the healing process was still far from complete. 
Wounds treated with neat PVA mat showed relatively 
better wound healing profiles compared to normal 
saline on days 7 and 14 post-surgery. This was evident 
from the smaller amounts of granulation tissue and 
greater re-epithelialization on days 7 and 14 (Figure 
8c) and especially from the higher collagen density 
on day 14 (Figure 9c). Histopathological findings in 
wounds treated with NAC 5% gel indicated relatively 
enhanced healing features compared to the normal 
saline group, which include lower levels of PMNs, new 
vessel formation and granulation tissue observed with 
re-epithelialization at a moderate (day 7) and high level 
(day 14) (Figure 8b). Collagen fiber production was 
also improved on days 7 and 14 (Figure 9b). In wounds 
treated with PVA/NAC 5% mats, re-epithelialization 
was more extensive than in the other groups on day 
7, and was nearly complete on day 14 post-surgery. 
Notably, wounds were covered with a keratin layer 
on day 14. Minimal levels of PMNs, granulation tissue 
and neovascularization were found, and PMNs were 
partially replaced by macrophages and lymphocytes 
(Figure 8d). In addition, collagen fibers were prominent 
throughout the wound bed, with high levels of fibroblast 
proliferation (Figure 9d). Although wounds treated with 
PVA/NAC 5% mats showed a better healing profile than 
other treatments, the development of skin appendages 
did not recover even after 14 days of topical treatment.
The results of semiquantitative analyses of the 
histopathological parameters were in accordance with 
the above descriptive findings. For the data from day 7, 
statistical analysis failed to detect significant differences 
among experimental groups in re-epithelialization 
(χ2=2.94, df=3, P=0.40), fibroblast growth (χ2=26.35, 
df=3, P=0.09), collagen density (χ2=6.49, df=3, P=0.09), 
PMNs (χ2=6.93, df=3, P=0.07), neovascularization (χ2 
=7.32, df=3, P=0.07), or granulation tissue (χ2=8.45, 
df=3, P=0.03) (Figure 10a). However, the data  for day 
14 post-surgery yielded significant differences among 
experimental groups in re-epithelialization (χ2=12.12, 
df=3, P=0.007), fibroblast growth (χ2=13.57, df=3, 
P=0.004), collagen density (χ2=16.59, df=3, P=0.001), 
PMNs (χ2=12.76, df=3, P=0.005), neovascularization 
(χ2=15.25, df=3, P=0.002), and granulation tissue 
 
  
Figure 9. Representative low-magnification (×40-100) photomicrographs 
of Masson’s trichrome-stained wound tissues treated with (a) normal 
saline, (b) NAC 5% gel, (c) neat PVA mat, or (d) PVA/NAC 5% mat 7 or 
14 days post-surgery. Collagen fibers were stained blue. The presence of 
collagen fibers was greatest in wounds treated with PVA/NAC 5% mats 
on day 14 post-surgery
NAC: N-acetylcysteine; PVA: Polyvinyl alcohol
 
  
Figure 10. Mean ranks of different histopathological parameters 
involved in wound healing after topical treatment of the wounds with 
normal saline, NAC 5% gel, neat PVA, or PVA/NAC 5% mats for (a) 7 
or (b) 14 days. The data were analyzed with the Kruskal–Wallis test 
followed by pairwise comparisons between groups (n=4–5/group)
* indicates significant differences (P < 0.05) compared to the normal 
saline group. NAC: N-acetylcysteine, PVA: Polyvinyl alcohol
NAC: N-acetylcysteine; PVA: Polyvinyl alcohol
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(χ2=13.13, df=3, P=0.004) (Figure 10b).  Although 
mean ranks of the parameters in NAC 5% gel and neat 
PVA mats showed better wound healing compared 
to normal saline, but the differences were not 
statistically significant. In contrast, mean ranks of 
re-epithelialization, fibroblast growth and collagen 
density in wounds treated with PVA/NAC 5% mats 
were significantly higher than wounds treated with 
normal saline (P=0.007, 0.002 and <001, respectively). 
In addition, in wounds treated with PVA/NAC 5% mats 
the parameters associated with wound inflammation 
were lower than wounds treated with normal saline, 
e.g. PMNs (P=0.003), neovascularization (P=0.001) and 
granulation tissue (P=0.002).
MDA and SOD assays
Lipid peroxidation (MDA level) in wound tissues was 
significantly affected after 7 (F=39.80, df=3, P<0.001) 
and 14 (F=55.09, df=3, P<0.001) days of treatment 
(Figure 11a).  Treatment with PVA/NAC 5% mats for 7 
days significantly reduced MDA levels by 48% compared 
to normal saline, and by 41% compared to neat PVA 
mats (both P<0.001). Similarly, NAC 5% gel significantly 
decreased MDA levels by 37% (P<0.001) compared to 
normal saline, and by 28% (P=0.001) compared to neat 
PVA mats. On day 14 post-surgery, lipid peroxidation 
was generally lower in all experimental groups than on 
day 7. Again, compared to treatment with normal saline, 
MDA levels were lower in wounds treated with (67%, 
P<0.001) and NAC 5% gel (47%, P<0.001). Compared to 
wounds treated with neat PVA mats, MDA levels were 
58% lower in the  PVA/NAC 5% mat group (P<0.001) 
and 41% lower in the NAC 5% gel group (P<0.001).
SOD activity differed significantly among experimental 
groups on day 7 post-surgery (F=32.61, df=3, P<0.001) 
(Figure 11b). Compared to treatment with normal 
saline, SOD activity was 68% higher in wounds treated 
with PVA/NAC 5% mats (P<0.001) and 59% higher 
after treatment with NAC 5% gel (P<0.001). Compared 
to treatment with neat PVA mats, SOD activity was 66% 
higher in the PVA/NAC 5% group and 56% higher in the 
NAC 5% group (both P<0.001). All experimental groups 
had lower levels of SOD activity on day 14 than on day 
7 post-surgery. However, the differences among groups 
remained statistically significant on day 14 post-surgery 
(F=6.60, df=3, P<0.001).  The highest levels of SOD 
activity were observed in wounds treated with PVA/
NAC 5% mats, and these values were 57% higher than 
those in wounds treated with normal saline (P=0.007) 
and 52% higher than wounds after treatment with PVA 
mats (P=0.027).
Discussion
The skin is the largest organ in the body, which plays 
a major role in maintaining homeostasis. Wound healing 
after physical, chemical and microbial insults is a key 
process in the recovery and regeneration of lost skin 
tissues. Effective wound healing is a multiphase process 
that is affected by a number of key determinants, 
especially the redox state of the wounded tissue. Because 
the wound healing process can be enhanced or hindered 
by a variety of factors (21), finding new methods and 
strategies to enhance wound healing is of great concern 
for researchers and clinicians.
The present study investigated the role of NAC, a 
potent anti-oxidant agent, in nanofiber mats tested in 
vivo and in vitro for their ability to favor wound healing. 
The main innovation in the present work is the use of 
nanotechnology to fabricate NAC-eluting nanofibrous 
mats, in order to take advantage of the high surface-to-
volume ratio, hydrophilicity and porosity of the mats to 
facilitate wound healing. A major finding was the ability of 
PVA-based fibrous mat containing NAC 5% to accelerate 
wound closure, enhance fibroblastic proliferation, and 
affect cellular and molecular processes in ways that 
favored enhanced wound healing. These effects can 
be attributed mainly to the suitable physicochemical 
properties of the fibers, and to the high capacity of NAC 
as a promising bioactive agent in the field of wound care.
Mats produced with PVA/NAC 5% generally 
exhibited a number of physicochemical properties 
required for effective wound dressings. PVA was chosen 
for electrospinning as a nontoxic polymer with high 
electrospinnability, which made it possible to blend 
NAC into PVA to fabricate electrospun nanofibers. The 
 
Figure 11. (a) MDA level and (b) SOD activity in wound tissues after 
treatment with normal saline, NAC 5% gel, neat PVA, or PVA/NAC 5% 
mats on day 7 or 14 post-surgery. The data were analyzed with one-
way ANOVA followed by the Tukey’s post hoc test. Bars represent the 
mean±standard deviation (n= 4–5/group). * and # indicate significant 
differences (P<0.05) compared to normal saline and neat PVA mats, 
respectively
MDA: Malondialdehyde; SOD: Superoxide dismutase; NAC: 
N-acetylcysteine; PVA: Polyvinyl alcohol
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addition of NAC to the PVA solution not only did not 
interfere with electrospinnability of the polymer, but in 
fact reduced fiber diameter as the concentration of NAC 
increased. This may be due to the increase in polarity 
and conductivity of the drug-containing solution (22). 
Surface-to-volume ratio is another significant variable, 
which is directly proportional to fiber size (23). Because 
PVA/NAC 5% mats demonstrated lower average fiber 
diameters, they can be assumed to have a higher 
surface-to-volume ratio. This would be an advantage in 
the wound healing process (24).
Porosity is another major parameter, which plays 
role in the fabrication of nanofiber mats for tissue 
regeneration and wound healing purposes. If a wound 
dressing mat is highly porous, more oxygen diffusion 
occurs in the wounded tissue and more fibroblasts can 
be accommodated between nanofibers, leading to the 
acceleration of wound healing (25). According to the 
findings for porosity, the higher NAC concentration (5% 
w/v) yielded higher porosity, which may be associated 
in part with the narrower fibers obtained with this NAC 
concentration.
The degree of swelling (hydrophilicity) and ability 
of a wound dressing mat to preserve water affects its 
effectiveness in wound healing. Because we found no 
significant difference in swelling between different 
mat formulations, we can attribute the similarity 
in swelling to the fact that all three mat types were 
composed of PVA.  However, swelling also depends on 
other parameters such as porosity, surface-to-volume 
ratio of the fibers, and the nature of the added drug 
(26, 27). Given that NAC is a hydrophilic chemical (28), 
we expected swelling to increase together with the 
concentration of NAC in fibers, as was observed in PVA/
NAC 5% mates compared to neat PVA mats. This finding 
can be attributed to hydrophilic interaction between 
NAC on the fiber surface and the aqueous medium. 
Although this effect of NAC was not strong enough to 
cause significant differences in swelling rates between 
the different 3 mats, the ability of PVA/NAC 5% mats to 
retain more water may help prevent wound dryness and 
nutrient loss, as well as promoting cellular proliferation 
and growth on the mat (29, 30).
A simple gravimetric assay was used to evaluate 
structural endurance of the electrospun fibers against 
PBS buffer at different time intervals. An important 
feature of any wound dressing mat is resistance to rapid 
disintegration when applied on the wound (31). Weight 
loss in fibers is closely associated with swelling, because 
swelling can lead to more rapid disintegration. In mats 
containing higher NAC levels, weight loss was slightly but 
nonsignificantly greater than neat PVA mat. The reason 
for this slightly higher weight loss in PVA/NAC 5% mats 
may be the same as for the swelling results discussed 
above. As an aqueous medium, PBS buffer makes full 
contact with hydrophilic surfaces and penetrates more 
easily into porous structures (32).
It is routine to evaluate drug effects on cell lines before 
tissues or the whole body in order to document how 
the targeted cells respond. We therefore investigated 
the biocompatibility of the nanofiber scaffolds with the 
MTT assay and SEM in the human foreskin fibroblastic 
cell line before implanting the nanofiber mats in 
animals. PVA/NAC 5% mats were nontoxic to the cells, 
and in fact promoted cell proliferation and attachment, 
an effect that can be attributed to the ability of NAC to 
promote cell proliferation (33). In line with our findings, 
Zhu et al. fabricated a NAC-containing nanoscaffold and 
showed that it had a positive effect on the viability of rat 
bone marrow-derived stroma cells (rBMSCs) (34).
In vivo wound healing experiments with our 
electrospun mats were carried out in full-thickness 
excisional wounds in mice for a period of 14 days. 
Throughout the experimental period, care was taken to 
maintain wound cleanliness, and no wound infections 
were observed. In addition to the PVA/NAC 5% mat, a 
simple NAC 5% gel formulation was included to study 
the effects of NAC alone in the absence of the nanofiber 
scaffold. Although wound closure was more evident in 
wounds treated with the NAC 5% gel and PVA/NAC 5% 
mat compared to other treatments on day 3, statistically 
significant wound closure was only observed on day 7 
and later. In line with this finding, Oguz et al. showed 
that NAC 3% cream resulted in significant wound 
closure in rats, and that the effect was time-dependent 
(35). Of note, the smallest wound area was obtained 
with the PVA/NAC 5% mat, which can be attributed 
in part to its specific surface properties that maintain 
wound moisture at an appropriate level and thereby 
favor wound closure. 
Analysis of the histopathological (microscopic) 
changes is another means of evaluating the wound 
healing process, which provides deeper information 
of the process and complements the macroscopic 
findings. Favorable histopathological parameters 
(more re-epithelialization, fibroblast proliferation and 
collagen synthesis, less inflammation and granulation 
tissue) were more pronounced in tissues treated with 
NAC 5% gel and especially with PVA/NAC 5% mats. 
These findings correspond well with our macroscopic 
results. In line with these findings, it was reported 
that cell proliferation, collagenous expression of MMP-
1 and re-epithelialization improved significantly 
after treatment with topical NAC in vitro and in vivo 
(36). In addition, Demir et al. showed that the oral or 
intraperitoneal administration of NAC to irradiated 
rats yielded better wound healing in terms of re-
epithelialization, perianastomotic wound fibrosis, and 
other histopathological parameters (37). In addition, 
the administration of NAC promoted healing in ulcers 
caused by bullous morphea in a clinical study (38).
NAC provides cysteine (a thiol-bearing amino acid), 
which is involved in glutathione replenishment. It 
also possesses anti-oxidant and anti-inflammatory 
properties (39). In the wound healing process, 
inflammatory cells, fibroblasts and other cells produce 
ROS, which at high levels may disturb normal wound 
repair by damaging proteins, lipid membranes and DNA 
(5). Hence, the administration of NAC would be expected 
to modulate the redox state of wound tissues in favor of 
facilitating wound healing. In the present study, the anti-
oxidant efficacy of topical treatments was investigated 
by measuring SOD activity and MDA levels in wound 
tissues to search for possible mechanistic explanations 
for the macroscopic and microscopic findings. As 
expected, NAC in the simple gel formulation or as a 
component in nanofibrous mats enhanced SOD activity 
(an important endogenous anti-oxidant enzyme) and 
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reduced the breakdown products of lipid peroxidation 
(MDA levels) in wound tissues. Endogenous anti-oxidant 
enzymes such SOD, catalase and others promote wound 
repair by scavenging ROS (40). Although both NAC gel 
and PVA/NAC 5% mats promoted SOD activity on day 
7 post-surgery, the effect was more pronounced latter, 
especially on day 14 post-surgery. The anti-oxidant 
effect of treatments was further evaluated by measuring 
MDA levels as a simple marker of the extent of oxidative 
damage in wound tissues. NAC-containing formulations 
produced lower MDA levels on day 7 and, to a greater 
extent, on day 14 post-surgery. In accordance with our 
findings, Aktunc et al. reported that the intraperitoneal 
administration of NAC (150 mg/kg) reduced MDA levels 
in wound tissues of both diabetic and nondiabetic 
mice compared to controls after 5 days of treatment 
(10). In addition, it was shown that NAC accelerated 
anastomotic wound healing, while decreasing serum 
MDA levels and increasing SOD activity in irradiated rats 
(37). Therefore, the present findings regarding the anti-
oxidant activity of NAC in early and late phases of healing 
link the observed accelerated wound repair with the 
elevated activity of endogenous anti-oxidant enzymes 
(e.g. SOD), which in turn  may lower the accumulation of 
lipid peroxidation products (MDA levels). 
Nanofibrous mats have been extensively studied 
as drug delivery systems with controlled or sustained 
release dynamics. The gradual release of the bioactive 
drug in the wound environment maintains appropriate 
concentrations of the drug for longer periods, and this 
in turn enhances wound repair especially in chronic 
wounds. We postulate that the beneficial effect we 
observed for PVA/NAC electrospun mats on wound 
healing and oxidative stress parameters may be 
associated in part with their drug release profile. Our 
NAC-loaded mats showed a biphasic release pattern 
with a total duration of up to 120 hrs. Most of the drug 
(approximately 80%) was released from the mats within 
the first 24 hrs, followed by sustained gradual release 
thereafter. This release profile is superior to the sudden-
burst release pattern, and can be considered acceptable 
for the once-daily topical regimen as tested in the 
present study. PVA-based electrospun mats are highly 
vulnerable to burst release of the loaded drug due to the 
high hydrophilicity of PVA in aqueous media (41). An 
efficient approach to overcome this disadvantage is to 
cross-link the nanofibrous mat, an approach we tested 
by using glutaraldehyde. Mats containing NAC 2.5% 
and 5% showed a similar drug release profile (Figure 
5), and this similarity was confirmed by the regression 
coefficients obtained in the kinetics models. Based 
on this finding, the initial rapid release of NAC was 
likely to be governed by a diffusion-controlled system 
attributable to the drug’s high hydrophilicity (42). The 
subsequent sustained release phase may be related to 
gradual swelling of the cross-linked PVA matrix, which 
would lead to slower NAC release from the polymer 
matrix (43). In addition, the probable hydrogen bonding 
between NAC and PVA molecules (Figure 4) may play 
part in delaying NAC release into the medium. In similar 
work, Hou et al. fabricated a sandwich-like nanofibrous 
scaffold with a polycaprolactone nanofiber filling 
enclosed by layers of collagen/NAC. They demonstrated 
sustained release of NAC from the mats, and provided 
in vitro and in vivo evidence of enhanced wound repair 
in experimental animals (44). In addition, Zhu et al. 
fabricated a dual-compartment nanofibrous scaffold 
containing NAC and examined its osteogenic potential in 
rBMSCs in vitro. The release kinetics curve showed that 
NAC followed a biphasic release profile with an initial 
burst release followed by a slower, sustained stage. 
This release profile of NAC was found to maintain high 
concentrations of the drug, and had a clear effect on the 
osteogenic differentiation of rBMSCs (34). 
Conclusion
The potent anti-oxidant agent NAC was incorporated 
into PVA solutions to produce electrospun nanofibrous 
mats characterized by thin and smooth nanofibers with 
desirable features in terms of porosity, hydrophilicity 
and in vitro drug release profile. The main finding of the 
present work was that PVA/NAC 5% mats accelerated 
wound repair efficiently at the macroscopic and 
microscopic level, and promoted fibroblast proliferation 
in vitro. Biochemical assays also provided evidence 
for the positive role of anti-oxidant activity of PVA/
NAC 5% in wound healing. The main advantages of the 
fabricated PVA/NAC 5% mats were the presence of NAC 
as a promising wound healing agent, and a nanofiber 
scaffold that provided a controlled drug release profile. 
Although the present findings for fabricated electrospun 
mats are still far from clinical application in humans, 
they are a step forward in the design and application of 
drug-eluting nanofiber scaffolds for wound care.
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